S 775 · 118th Congress
Increasing Transparency in Generic Drug Applications Act
<p><b>Increasing Transparency in Generic Drug Applications Act</b></p> <p>This bill requires the Food and Drug Administration (FDA) to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons w…
- Sponsor
- Hassan, Margaret Wood (D-NH)
- Introduced
- 2023-03-14
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍